Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
AZN US​

Astrazeneca Plc(AZN US)

$171.49-1.080.63%Ext:$169.17-2.321.35%(Market Closed · 00:00:04 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings by Owner

Insider Ownership

ASTRAZENECA PLC(15)

  • 4Statement of changes in beneficial ownership16 Mar 2021
  • 3Initial statement of beneficial ownership7 Feb 2020
  • 4Statement of changes in beneficial ownership7 Feb 2020
  • 4Statement of changes in beneficial ownership9 Oct 2019
  • 3Initial statement of beneficial ownership2 Oct 2019
  • 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019
  • 4Statement of changes in beneficial ownership24 Oct 2018
  • 3Initial statement of beneficial ownership17 Oct 2018
  • 4Statement of changes in beneficial ownership2 Oct 2018
  • 3Initial statement of beneficial ownership25 Sep 2018

Sharma Mani(8)

  • 4PRIMARY DOCUMENT8 Oct
  • 4OWNERSHIP DOCUMENT11 Sep
  • 4PRIMARY DOCUMENT7 Aug
  • 4OWNERSHIP DOCUMENT8 Jul
  • 4OWNERSHIP DOCUMENT16 Jun
  • 4OWNERSHIP DOCUMENT22 May
  • 4OWNERSHIP DOCUMENT8 May
  • 3OWNERSHIP DOCUMENT19 Mar

ASTRAZENECA AB(6)

  • 4Statement of changes in beneficial ownership2 Oct 2018
  • 3Initial statement of beneficial ownership25 Sep 2018
  • 4Statement of changes in beneficial ownership5 Dec 2017
  • 3Initial statement of beneficial ownership7 Nov 2016
  • 4Statement of changes in beneficial ownership14 Nov 2014
  • 3Initial statement of beneficial ownership12 Oct 2012

AstraZeneca UK LTD(3)

  • 4Statement of changes in beneficial ownership16 Mar 2021
  • 4Statement of changes in beneficial ownership9 Oct 2019
  • 3/AInitial statement of beneficial ownership (amendment)9 Oct 2019

Zeneca, Inc.(2)

  • 4Statement of changes in beneficial ownership24 Oct 2018
  • 3Initial statement of beneficial ownership17 Oct 2018

MedImmune Ltd(2)

  • 3Initial statement of beneficial ownership7 Feb 2020
  • 4Statement of changes in beneficial ownership7 Feb 2020

≥5% Ownership

ASTRAZENECA PLC(37)

  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • SC 13G/AConduit Pharmaceuticals Inc.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GConduit Pharmaceuticals Inc.11 Oct 2024
  • SC 13G/AADC Therapeutics SA12 Feb 2024
  • SC 13D/ACellectis S.A.16 Nov 2023
  • SC 13DCellectis S.A.9 Nov 2023
  • SC 13G/APieris Pharmaceuticals, Inc.10 Feb 2023

BlackRock Inc.(17)

  • SC 13G/AAstrazeneca Plc24 Jan 2024
  • SC 13G/AAstrazeneca Plc24 Jan 2023
  • SC 13GAstrazeneca Plc8 Jul 2022
  • SC 13G/AAstrazeneca Plc7 Feb 2022
  • SC 13G/AAstrazeneca Plc29 Jan 2021
  • SC 13G/AAstrazeneca Plc5 Feb 2020
  • SC 13G/AAstrazeneca Plc4 Feb 2019
  • SC 13G/AAstrazeneca Plc30 Jan 2018
  • SC 13G/AAstrazeneca Plc19 Jan 2017
  • SC 13G/AAstrazeneca Plc10 Feb 2016

WELLINGTON MANAGEMENT GROUP LLP(8)

  • SC 13G/AAstrazeneca Plc4 Feb 2022
  • SC 13G/AAstrazeneca Plc3 Feb 2021
  • SC 13G/AAstrazeneca Plc27 Jan 2020
  • SC 13G/AAstrazeneca Plc12 Feb 2019
  • SC 13G/AAstrazeneca Plc8 Feb 2018
  • SC 13G/AAstrazeneca Plc9 Feb 2017
  • SC 13G/AAstrazeneca Plc11 Feb 2016
  • SC 13GAstrazeneca Plc12 Feb 2015

CAPITAL RESEARCH & MANAGEMENT CO(7)

  • SC 13G/AAstrazeneca Plc13 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc10 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13G/AAstrazeneca Plc13 Feb 2003
  • SC 13GAstrazeneca Plc15 Feb 2002

CAPITAL GROUP INTERNATIONAL INC(6)

  • SC 13G/AAstrazeneca Plc12 Feb 2008
  • SC 13G/AAstrazeneca Plc12 Feb 2007
  • SC 13G/AAstrazeneca Plc9 Feb 2006
  • SC 13G/AAstrazeneca Plc11 Feb 2005
  • SC 13G/AAstrazeneca Plc13 Feb 2004
  • SC 13GAstrazeneca Plc11 Feb 2003

MERRILL LYNCH & CO INC(2)

  • SC 13G/AAstrazeneca Plc4 Feb 2000
  • SC 13GZeneca Group Plc5 Feb 1999

INVESTOR AB(2)

  • SC 13D/AAstrazeneca Plc17 Feb 2004
  • SC 13DAstrazeneca Plc8 Jul 2002

BlackRock, Inc.(1)

  • SC 13G/AAstrazeneca Plc23 Apr 2025

VANGUARD CAPITAL MANAGEMENT LLC(1)

  • SC 13GAstrazeneca Plc28 Apr